Eleanor Wilson (she/her/hers) is a partner in the Intellectual Property Group at Cassels. Eleanor’s practice encompasses all types of intellectual property disputes, including those involving patent, copyright, trademark, and industrial design issues. Her significant litigation experience has included acting as counsel on trials, appeals, motions, applications, and mediations. She also provides strategic and practical advice on a range of regulatory matters, life-cycle management of pharmaceuticals, and commercial intellectual property matters.
Eleanor offers particular expertise in patent-related matters, including actions under the Patent Act and the Patented Medicines (Notice of Compliance) Regulations, and has represented clients within various industries spanning pharmaceuticals and life sciences, technology, cannabis, food science, and consumer goods. She regularly combines her legal acumen with her science background to advocate for clients and find creative approaches to complex issues.
Eleanor’s representative work includes acting for:
- Janssen, Aragon, and Sloan-Kettering Institute in patent infringement actions relating to the medicine Erleada (apalutamide)
- WhiteWater West Industries in a patent and industrial design infringement and impeachment action relating to water slides (Proslide v WhiteWater, 2024 FC 1439)
- A Canadian university in a copyright infringement action against a tutoring company
- A baby products company in the damages phase of a patent infringement action
- Janssen and AbbVie in patent infringement actions relating to the medicine Imbruvica (ibrutinib)
- A food ingredient company in a patent infringement action relating to meat curing
- A fermentation company in a patent infringement action relating to cannabis
- An innovator pharmaceutical company in a patent infringement action relating to a medicine used to treat type 2 diabetes
- Innovator pharmaceutical companies in a patent infringement action relating to a medicine used to treat opioid overdose
- An innovator pharmaceutical company in multiple patent infringement actions relating to a medicine used to treat multiple myeloma and myelodysplastic syndromes
Prior to joining Cassels, Eleanor was an associate at another national full-service firm, specializing in intellectual property litigation.
